HighMark Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
HighMark Wealth Management's AMGN Position: Q3 2026 in Review
HighMark Wealth Management increased its Amgen (AMGN) stake by 15% in Q3 2026, buying an estimated $1.2K and bringing the position to 23 shares worth $9.8K. The position accounts for ﹤0.01% of the portfolio, ranked #338.
HighMark Wealth Management first reported a position in AMGN in Q4 2019 and has held it in 28 quarters since. The position peaked at $12.5K in Q2 2025. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- HighMark Wealth Management held 23 shares of Amgen worth $9.8K as of Q3 2026.
- HighMark Wealth Management bought 3 Amgen shares in Q3 2026, an estimated $1.2K.
- Amgen made up ﹤0.01% of HighMark Wealth Management's portfolio in Q3 2026, its #338 holding.
- HighMark Wealth Management first reported a position in Amgen in Q4 2019 and has held it in 28 quarters since.
- HighMark Wealth Management's Amgen position peaked at $12.5K in Q2 2025.
- 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on HighMark Wealth Management's 13F filing for Q3 2026, filed 17 Nov 2026.